Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
| ▸ | CA2 | P00918 | 3/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15495875 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15495919 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15495814 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15495810 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15496142 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL18436006 | 0.98 | SIGMAR1 (0.33) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL17153719 | 0.98 | PDK2 (0.34) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15495893 | 0.98 | SIGMAR1 (0.33) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL16366106 | 0.98 | SIGMAR1 (0.36) | SIGMAR1PDK2CA12CA1CA2 | |
| SCHEMBL15495861 | 0.98 | SIGMAR1 (0.36) | SIGMAR1PDK2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180226601-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, DISPLAY DEVICE, AND MIXED MATERIAL | IDEMITSU KOSAN CO., LTD. (JP) | 2018-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180226601-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, DISPLAY DEVICE, AND MIXED MATERIAL | TMEM109, L1CAM, CD99 | SIGMAR1 1110/4885PDK2 1665/4885CA12 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.